ImageneBio IMA
NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT

ImageneBio (IMA) Shares Outstanding (2020 - 2025)

ImageneBio's (IMA) quarterly Shares Outstanding (Entity) came in at $8.5 million in Q3 2025, up 112.04% year-over-year from $4.0 million in Q3 2024, and up 112.04% quarter-over-quarter from $4.0 million in Q2 2025.

Analysis

ImageneBio (IMA) Shares Outstanding (2020 - 2025) Analysis & Trends

ImageneBio has disclosed Shares Outstanding (Entity) across 6 years of filings, most recently posting $8.5 million for Q3 2025.

  • In Q3 2025, Shares Outstanding (Entity) rose 112.04% year-over-year to $8.5 million; the TTM figure through Sep 2025 stood at $8.5 million (up 112.04% YoY), while the FY2024 annual figure was $4.0 million, changed 0.0% from the prior year.
  • Shares Outstanding (Entity) came in at $8.5 million for Q3 2025 at ImageneBio, up from $4.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $8.5 million in Q3 2025 to a low of $320842.0 in Q1 2021.
  • Average Shares Outstanding (Entity) over 5 years is $3.6 million, with a median of $3.5 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Entity) soared 1249.4% in 2021 and changed 0.0% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $2.3 million in 2021, then gained by 29.57% to $3.0 million in 2022, then jumped by 33.1% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024, then jumped by 112.04% to $8.5 million in 2025.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $8.5 million in Q3 2025, $4.0 million in Q2 2025, and $4.0 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 720.78 Mn
10 ImageneBio 42.89 Mn -92.46 Mn - 8.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8.53 Mn
Sep 30, 2025 8.53 Mn
Jun 30, 2025 4.02 Mn
Mar 31, 2025 4.02 Mn
Dec 31, 2024 4.02 Mn
Sep 30, 2024 4.02 Mn
Jun 30, 2024 4.02 Mn
Mar 31, 2024 4.02 Mn
Dec 31, 2023 3.48 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 3.27 Mn
Mar 31, 2023 3.02 Mn
Dec 31, 2022 3.02 Mn
Sep 30, 2022 3.02 Mn
Jun 30, 2022 3.01 Mn
Mar 31, 2022 3.01 Mn
Dec 31, 2021 2.33 Mn
Sep 30, 2021 2.99 Mn
Jun 30, 2021 2.99 Mn
Mar 31, 2021 320,842.00